Insider Selling: Veru Inc (VERU) Insider Sells 10,455 Shares of Stock
Veru Inc (NASDAQ:VERU) insider Mitchell Shuster Steiner sold 10,455 shares of the business’s stock in a transaction dated Friday, February 8th. The stock was sold at an average price of $1.50, for a total transaction of $15,682.50. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Mitchell Shuster Steiner also recently made the following trade(s):
- On Wednesday, January 23rd, Mitchell Shuster Steiner sold 25,600 shares of Veru stock. The stock was sold at an average price of $1.34, for a total transaction of $34,304.00.
VERU stock remained flat at $$1.49 during trading on Friday. 196,594 shares of the company were exchanged, compared to its average volume of 77,860. The stock has a market capitalization of $93.47 million, a P/E ratio of -3.82 and a beta of 0.87. Veru Inc has a 52-week low of $1.20 and a 52-week high of $2.37. The company has a current ratio of 0.83, a quick ratio of 0.66 and a debt-to-equity ratio of 0.09.
A number of hedge funds have recently added to or reduced their stakes in VERU. Perceptive Advisors LLC purchased a new stake in Veru during the third quarter worth about $2,024,000. AWM Investment Company Inc. boosted its holdings in Veru by 72.4% during the third quarter. AWM Investment Company Inc. now owns 1,000,000 shares of the company’s stock worth $1,420,000 after buying an additional 420,000 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of Veru by 475.1% in the second quarter. BlackRock Inc. now owns 113,563 shares of the company’s stock valued at $229,000 after purchasing an additional 93,815 shares in the last quarter. Hound Partners LLC purchased a new stake in shares of Veru in the third quarter valued at about $119,000. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Veru by 328.8% in the third quarter. Dimensional Fund Advisors LP now owns 102,909 shares of the company’s stock valued at $146,000 after purchasing an additional 78,909 shares in the last quarter. 8.57% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts have recently issued reports on the stock. HC Wainwright set a $5.00 price target on shares of Veru and gave the stock a “buy” rating in a research note on Friday, December 14th. Zacks Investment Research upgraded shares of Veru from a “sell” rating to a “buy” rating and set a $1.50 price target on the stock in a research note on Wednesday, October 17th. Five research analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and a consensus price target of $5.33.
TRADEMARK VIOLATION WARNING: “Insider Selling: Veru Inc (VERU) Insider Sells 10,455 Shares of Stock” was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://theolympiareport.com/2019/02/09/insider-selling-veru-inc-veru-insider-sells-10455-shares-of-stock.html.
Veru Company Profile
Veru Inc operates as an oncology and urology biopharmaceutical company. The company operates through two segments, Commercial, and Research and Development. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of premature ejaculation.
Further Reading: How Do You Calculate Return on Equity (ROE)?
Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.